Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2026)

Collegium Pharmaceutical has reported FCF Margin over the past 10 years, most recently at 59.89% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1288.0% year-over-year to 59.89%; the TTM value through Dec 2025 reached 42.15%, down 51.0%, while the annual FY2025 figure was 42.15%, 972.0% up from the prior year.
  • FCF Margin for Q4 2025 was 59.89% at Collegium Pharmaceutical, up from 37.37% in the prior quarter.
  • Over five years, FCF Margin peaked at 93.1% in Q4 2021 and troughed at 699.39% in Q1 2022.
  • A 5-year average of 1.43% and a median of 38.13% in 2025 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: plummeted -72236bps in 2022 and later soared 71839bps in 2023.
  • Year by year, FCF Margin stood at 93.1% in 2021, then crashed by -46bps to 50.44% in 2022, then fell by -3bps to 49.06% in 2023, then dropped by -4bps to 47.01% in 2024, then rose by 27bps to 59.89% in 2025.
  • Business Quant data shows FCF Margin for COLL at 59.89% in Q4 2025, 37.37% in Q3 2025, and 38.89% in Q2 2025.